Why Processa Pharmaceuticals (PCSA) Shares Are Nosediving

Zinger Key Points
  • Processa Pharmaceuticals shares are trading lower by 23% during Thursday's session.
  • The company announced it will effect a 1-for-20 reverse stock split.


Processa Pharmaceuticals Inc PCSA shares are trading lower by 23% to $0.21 during Thursday’s session after the company announced it will effect a 1-for-20 reverse stock split.

The 1-for-20 reverse stock split is intended to meet Nasdaq’s minimum bid price requirement. Effective January 22, the common stock will trade on a split-adjusted basis.

This move reduces outstanding shares from 24.6 million to 1.2 million, with proportional adjustments to equity awards and warrants. Fractional shares won’t be issued.

Continental Stock Transfer & Trust will be the exchange agent for the reverse stock split.

See Also: Bitcoin, Ethereum Fall Following Jobless Claims Data

According to data from Benzinga Pro, PCSA has a 52-week high of $1.27 and a 52-week low of $0.18.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Newswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...